| Internal Activation of Peptidyl Prolyl Thioesters in Native Chemical Ligation Y Gui, L Qiu, Y Li, H Li, S Dong Journal of the American Chemical Society 138 (14), 4890-4899, 2016 | 69 | 2016 |
| Crystal nucleation rates in glass-forming molecular liquids: D-sorbitol, D-arabitol, D-xylitol, and glycerol C Huang, Z Chen, Y Gui, C Shi, GGZ Zhang, L Yu The Journal of chemical physics 149 (5), 054503, 2018 | 64 | 2018 |
| Polymorphism of Piroxicam: New Polymorphs by Melt Crystallization and Crystal Structure Prediction C Yao, IA Guzei, Y Jin, S Ruan, G Sun, Y Gui, L Wang, L Yu Crystal Growth & Design, 2020 | 43 | 2020 |
| A Mechanism for Reversible Solid-State Transitions Involving Nitro Torsion Y Gui, X Yao, IA Guzei, MM Aristov, J Yu, L Yu Chemistry of Materials 32 (18), 7754-7765, 2020 | 38 | 2020 |
| Polymorphic selectivity in crystal nucleation Y Gui, C Huang, C Shi, T Stelzer, GGZ Zhang, L Yu The Journal of Chemical Physics 156 (14), 144504, 2022 | 34 | 2022 |
| Amorphous Drug–Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Case of Clofazimine and Poly (acrylic acid) Y Gui, EC McCann, X Yao, Y Li, KJ Jones, L Yu Molecular Pharmaceutics 18 (3), 1364, 2021 | 32 | 2021 |
| Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines A Xiao, XJ Zheng, C Song, Y Gui, CX Huo, XS Ye Organic & biomolecular chemistry 14 (30), 7226-7237, 2016 | 32 | 2016 |
| Gelatin Nano-coating for Inhibiting Surface Crystallization of Amorphous Drugs R Teerakapibal, Y Gui, L Yu Pharmaceutical research 35 (1), 23, 2018 | 28 | 2018 |
| Improving Stability and Dissolution of Amorphous Clofazimine by Polymer Nano-Coating Y Gui, Y Chen, Z Chen, KJ Jones, L Yu Pharmaceutical Research 36 (5), 67, 2019 | 23 | 2019 |
| Inhibiting Surface Crystallization and Improving Dissolution of Amorphous Loratadine by Dextran Sulfate Nanocoating A Zeng, X Yao, Y Gui, Y Li, KJ Jones, L Yu Journal of pharmaceutical sciences 108 (7), 2391-2396, 2019 | 21 | 2019 |
| Surface-enhanced crystal nucleation and polymorph selection in amorphous posaconazole X Yao, KA Borchardt, Y Gui, IA Guzei, GGZ Zhang, L Yu The Journal of Chemical Physics 157 (19), 2022 | 20 | 2022 |
| Surfactants Accelerate Crystallization of Amorphous Nifedipine by Similar Enhancement of Nucleation and Growth Independent of Hydrophilic–Lipophilic Balance X Yao, EG Benson, Y Gui, T Stelzer, GGZ Zhang, L Yu Molecular Pharmaceutics, 2022 | 20 | 2022 |
| Amorphous drug-polymer salt with high stability under tropical conditions and fast dissolution: The challenging case of lumefantrine-PAA X Yao, S Kim, Y Gui, Z Chen, J Yu, KJ Jones, L Yu Journal of Pharmaceutical Sciences, 2021 | 19 | 2021 |
| Surface Enhancement of Crystal Nucleation in Amorphous Acetaminophen H Wu, X Yao, Y Gui, H Hao, L Yu Crystal Growth & Design, 2022 | 14 | 2022 |
| Origins and Implications of Extraordinarily Soft Crystals in a Fixed-Dose Combination Hepatitis C Regimen R Miglani Bhardwaj, R Ho, Y Gui, P Brackemeyer, G Schneider-Rauber, ... Crystal Growth & Design, 2022 | 11 | 2022 |
| Prolific Polymorph Generator ROY in Its Liquid and Glass: Two Conformational Populations Mirroring the Crystalline-State Distribution Z Chen, Y Gui, K Cui, JR Schmit, L Yu The Journal of Physical Chemistry B, 2021 | 8 | 2021 |
| Crystal Energy Landscape of Nifedipine by Experiment and Computer Prediction Y Gui, Y Jin, S Ruan, G Sun, V López-Mejías, L Yu Crystal Growth & Design, 2022 | 5 | 2022 |
| Phase Transitions in Molecular Solids: Understanding Polymorphic Transformation and Crystal Nucleation, and Engineering Amorphous Drugs for Global Health Y Gui The University of Wisconsin-Madison, 2021 | 4 | 2021 |
| Solid Form Screenings in Pharmaceutical Development: a Perspective on Current Practices Y Gui Pharmaceutical Research, 1-8, 2023 | 3 | 2023 |
| Conformational Distribution of a Prolific Polymorph Generator ROY in Its Liquid and Glass Z Chen, Y Gui, K Cui, L Yu Structure of Molecular Glasses: Determination and Control, 123, 2021 | 1 | 2021 |
Zhenxuan ChenMerck & Co.Patvirtintas el. paštas merck.com
